Should the European Medicines Agency consider ageing a disease?

The classification of ageing as a disease is fundamental to developing new pharmacological strategies that can target said phenomenon. The European Medicines Agency does not do this and maintains a questionable perspective based on the traditional naturalistic argument and the value‐free ideal. An a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Bioethics 2024-06, Vol.38 (5), p.431-437
1. Verfasser:	Marín Penella, Guillermo
Format:	Artikel
Sprache:	eng
Schlagworte:	ageing Aging antiageing medicines Bioethics Decision making Drugs Europe European Medicines Agency Humans lifespan longevity Pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!